Explore Cell Therapy

03 - Relationships Between Hematology/Oncology Practices and Transplant Centers, Pt. 2: Addressing Barriers and Equity with Shared Care

In part two of this episode, Kelley Steffens, Dr. Woods, and Dr. Stefanski dig deeper into barriers to care and health equity concerns for adult and pediatric patients in need of HCT. They go on to discuss how building relationships, connectivity, and shared care between hematology/oncology practices and transplant centers can help, and ways to apply these principles to clinical practice. 
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

03 - Relationships Between Hematology/Oncology Practices and Transplant Centers, Pt. 1: The Impact of Sharing Care and Timing

In a two-part episode on Evidence for Shared Care in HCT, our expert guests discuss recent research supporting strong relationships between hematology/oncology and transplant center care teams. Wendy Woods (formally Woods-Swafford), MD, MPH of Blank Children’s Hospital, and Heather Stefanski, MD, PhD of the National Marrow Donor Program® (NMDP)/Be The Match®, join Kelley Steffens, principal investigator and research manager at NMDP/Be The Match, to examine research findings and discuss best practices for shared or coordinated care to address access, barriers to care, and equity concerns in HCT. 
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

02 - Overcoming Barriers to HCT and Improving Access, Pt. II: Health Equity, Solutions and Building Trust via Shared Care

In this two-part episode, Karen Ballen, MD, of University of Virginia Health, and Mitul Gandhi, MD, of Virginia Cancer Specialists discuss recent research around access to HCT, as well as overcoming HCT barriers through coordinated care between transplant centers and hematology/oncology practices. In Part II: Health Equity, Solutions and Building Trust via Shared Care, they examine health disparities in access for ethnically diverse patients, propose solutions to overcome barriers for all in need of HCT, and stress the importance of shared and coordinated care between providers on the path to transplant.
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 
 

02 – Overcoming Barriers to HCT and Improving Access, Pt. I: Barriers in HCT and the Importance of Time

In this two-part episode, Karen Ballen, MD, of University of Virginia Health, and Mitul Gandhi, MD, of Virginia Cancer Specialists discuss recent research around access to HCT, as well as overcoming HCT barriers through coordinated care between transplant centers and hematology/oncology practices. In Part I: Barriers in HCT and the Importance of Time, they discuss major findings from Dr. Ballen’s recent research and explore the importance of early consultation to give patients, caregivers, and providers more time to ensure optimal outcomes. 
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 
 

01 - Advances in HCT Over Time, Pt. III: Persistent Misconceptions, Coordinated Care and the Future of HCT

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part 3: Persistent Misconceptions, Coordinated Care and the Future of HCT, they discuss the challenge and importance of understanding when, who, and how to refer for a transplant consultation, promoting coordinated care and open communication across the care team. They also discuss emerging advances and the future of HCT, including CAR-T and treatments for sickle cell and thalassemia. For more information, resources from the episode, or full bios of our guests, visit our site. 

01 - Advances in HCT Over Time, Pt. II: Donor Availability, Graft Sources and the Birth of NMDP

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part 2: Donor Availability, Graft Sources and the Birth of NMDP, they discuss how unrelated donor availability and alternative stem cell sources have substantially increased access to HCT. They share the story of the first unrelated donor transplant for leukemia, performed at Fred Hutch in 1979, and how it led to the development of the NMDP/Be The Match Registry. 
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

01 - Advances in HCT Over Time, Pt. I: Transplant Then and Now

This three-part episode follows a discussion of the current state of HCT by exploring its evolution over time. Fred Appelbaum, MD, of Fred Hutchinson Cancer Center, and Courtney Bellomo, MD, of New York Oncology Hematology lead the discussion. In Part I: Transplant Then and Now, they examine what HCT looked like when they first started practicing compared to what it is today, learning alongside E. Donnall Thomas, Nobel Prize winner in HCT. Major advances in HCT and access to care are explored. 
To read bios on the panelists and to access additional resources related to this episode, visit Our Site. 

Three Guests, Three Stories, Three Perspectives: Expanding Access to Transplants for Latinx Patients

Hosted by Amaro Sanchez, Be The Match Transplant Center Liaison for Latin America, our three guests will analyze, through three different cases, the outlook, progress and future challenges of transplant access for Latinx patients.

3500 Miles: How Bob Falkenberg is Using His Bike to Inspire Thrivorship

Join us as we connect with Bob Falkenberg, recipient and founder of Team Lifeblood and the Tour de TC bicycle ride. Bob started riding post-transplant to focus on wellness, he rides today to bring hope to patients undergoing transplant and to share one version of what survivorship can look like. In the second half of our podcast we’ll be joined by Be The Match subject matter experts on survivorship, Katie Shoeppner and Angela Woods. Katie and Angela know that there are as many versions of survivorship as there are patients and they will share how Be The Match is working with patients and transplant centers to explore this area of the transplant journey.

Your Feedback: How Small Survey Questions are Driving Big Impact

If you are an NMDP/Be The Match Network partner, chances are, you have completed at least one survey in the past year. But where does your feedback go? Does anyone actually read your comments? Listen in to learn how your unique perspectives have been used to impact important changes in how NMDP/Be The Match serves you and your patients.